Literature DB >> 15710413

L-dopa and dopamine enhance the formation of aggregates under proteasome inhibition in PC12 cells.

Yuko Yoshimoto1, Kazuhiro Nakaso, Kenji Nakashima.   

Abstract

The formation of inclusion bodies in dopaminergic neurons is associated with the pathogenesis of Parkinson's disease. In order to clarify the role of dopamine/L-dopa in the formation of protein aggregates, we investigated dopamine/L-dopa-related aggregation using an experimental inclusion model. The inhibition of tyrosine hydroxylase (TH) by alpha-methyltyrosine dramatically decreased MG132-induced aggregate formation. In addition, the inhibition of TH caused the upregulation of proteasomes in cultured cells and the dopamine/L-dopa induced non-enzymatic polymerization of ubiquitin. This inhibition did not affect cell viability. These results suggest that dopamine/L-dopa might enhance aggregate formation, and that intracellular aggregates may not be toxic to cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710413     DOI: 10.1016/j.febslet.2004.12.091

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

Review 1.  Protein degradation pathways in Parkinson's disease: curse or blessing.

Authors:  Darius Ebrahimi-Fakhari; Lara Wahlster; Pamela J McLean
Journal:  Acta Neuropathol       Date:  2012-06-29       Impact factor: 17.088

2.  skn-1-Dependent and -independent regulation of aip-1 expression following metabolic stress in Caenorhabditis elegans.

Authors:  Annabel A Ferguson; Mitchell G Springer; Alfred L Fisher
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

3.  Dopamine induces supernumerary centrosomes and subsequent cell death through Cdk2 up-regulation in dopaminergic neuronal cells.

Authors:  Francisco J Diaz-Corrales; Masato Asanuma; Ikuko Miyazaki; Ko Miyoshi; Nobutaka Hattori; Norio Ogawa
Journal:  Neurotox Res       Date:  2008-12       Impact factor: 3.911

Review 4.  Approaches to prevent dopamine quinone-induced neurotoxicity.

Authors:  Ikuko Miyazaki; Masato Asanuma
Journal:  Neurochem Res       Date:  2008-09-04       Impact factor: 3.996

5.  Dopamine-mediated oxidation of methionine 127 in α-synuclein causes cytotoxicity and oligomerization of α-synuclein.

Authors:  Kazuhiro Nakaso; Naoko Tajima; Satoru Ito; Mari Teraoka; Atsushi Yamashita; Yosuke Horikoshi; Daisuke Kikuchi; Shinsuke Mochida; Kenji Nakashima; Tatsuya Matsura
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

Review 6.  Seeding of proteins into amyloid structures by metabolite assemblies may clarify certain unexplained epidemiological associations.

Authors:  Dorin Sade; Shira Shaham-Niv; Zohar A Arnon; Omid Tavassoly; Ehud Gazit
Journal:  Open Biol       Date:  2018-01       Impact factor: 6.411

Review 7.  The Proteasome Inhibition Model of Parkinson's Disease.

Authors:  Eduard Bentea; Lise Verbruggen; Ann Massie
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

8.  Transfer of disrupted-in-schizophrenia 1 aggregates between neuronal-like cells occurs in tunnelling nanotubes and is promoted by dopamine.

Authors:  Seng Zhu; Saïda Abounit; Carsten Korth; Chiara Zurzolo
Journal:  Open Biol       Date:  2017-03       Impact factor: 6.411

9.  Cytoprotective effect of chlorogenic acid against α-synuclein-related toxicity in catecholaminergic PC12 cells.

Authors:  Mari Teraoka; Kazuhiro Nakaso; Chiaki Kusumoto; Satoshi Katano; Naoko Tajima; Atsushi Yamashita; Teppei Zushi; Satoru Ito; Tatsuya Matsura
Journal:  J Clin Biochem Nutr       Date:  2012-04-06       Impact factor: 3.114

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.